Karanth S. Predictors of mortality among coronavirus disease 2019 (COVID-19) patients in a large hospital system. Poster presented at the 2021 American Thoracic Society (ATS) International Conference; 2021. [abstract] Am J Respir Crit Care Med. 2021 May 1; 203(9). doi: 10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A2650
Karanth S, Ayad M, Murphy R, Patel B. Improvements in physician notification time after implementing St. John sepsis surveillance agent alert in a large multi-hospital health system. Poster presented at the 2020 American Thoracic Society (ATS) International Conference; May 2020. [abstract] Am J Respir Crit Care Med. 2020; 201:A5305. doi: 10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A5305
Ayad M, Karanth S, Patel B. Lactate levels at 6 hrs. is more prognostic of in hospital mortality than a >=50 % lactate clearance in severe sepsis. Poster presented at the 2019 American Thoracic Society (ATS) International Conference; May 2019. Dallas, TX. [abstract] Am J Respir Crit Care Med. 2019; 199:A6704. doi: 10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A6704
Patil S, Karanth S, Ayad M, Vijhani P, Kaushal S, Sen A, Gopal K, Patel B. Delayed dose of pharmacological VTE prophylaxis and VTE incidence in hospitalized patients. Poster presented at the 2018 American Thoracic Society (ATS) International Conference; May 2018. [abstract] Am J Respir Crit Care Med. 2018 Mar;.
Donohue IF, Bollu VK, Stull DE, Nelson LM, Williams VS, Stensland MD, Hanania NA. Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial. Int J Chron Obstruct Pulmon Dis. 2018 Feb 5;13:499-508.
Karanth S, Patil S, Ayad M, Sen A, Gopal K, Gomez K, Patel B. Patterns in VTE prophylaxis dose delays among hospitalized patients. Poster presented at the 2018 American Thoracic Society (ATS) International Conference; May 2018. San Diego, CA. [abstract] Am J Respir Crit Care Med. 2018; 197:A6833.
Wilson MR, Patel JG, Coleman A, McDade CL, Stanford RH, Earnshaw SR. Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model. Int J Chron Obstruct Pulmon Dis. 2017 Mar 24;2017(12):997-1008.
Diette GB, Dalal AA, D'Souza AO, Lunacsek O, Nagar SP. Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States. Int J Chron Obstruct Pulmon Dis. 2015 Feb 24;10:415-22.
Patel JG, Nagar SP, Dalal AA. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstruct Pulmon Dis. 2014 Mar;19(9):289-300.
Hopkinson NS, Nickol AH, Payne J, Hawe E, Man WD, Moxham J, Montgomery H, Polkey MI. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(4):395-9.
Woods DR, Pollard AJ, Collier DJ, Jamshidi Y, Vassiliou V, Hawe E, Humphries SE, Montgomery HE. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and arterial oxygen saturation at high altitude. Am J Respir Crit Care Med. 2002;166(3):362-6.
Bauman KE, Foshee VA, Ennett ST, Hicks K, Pemberton M. Family matters: a family-directed program designed to prevent adolescent tobacco and alcohol use. Health Promot Pract. 2001 Jan 1;2(1):81-96.